Schedule 13G ownership disclosure
JOUNCE THERAPEUTICS INC
Security class unavailable · CUSIP: 481116101
Event date: 2022-03-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-011994
- Form type
- SC 13G
- Filer
- Jounce Therapeutics, Inc.
- CIK
- CIK 1640455
- Filed
- Apr 12, 2023
- Reporting period
- Mar 30, 2022
- Description
- Schedule 13G beneficial ownership